Kras G13D Nucleotide Exchange Assay Kit

Background

Kras is a member of the RAS protein family, which are a class of small GTPases involved in cell signaling pathways. The Ras signaling pathway plays an important role in cell proliferation and differentiation. Conversion of Kras from the inactive GDP-bound state to the active GTP-bound state triggers the downstream effector and promotes cell growth. RAS genes are frequently mutated in various human tumors. These mutations block the GTPase activity of RAS and lock RAS in the GTP- bound state, resulting in constitutively active signals through the downstream cascades leading to cancer cell proliferation.

Assay Principle

The Kras (G13D) nucleotide exchange assay is a TR-FRET based assay. The assay kit is designed to detect the GTP binding status of Kras mutant (G13D). The Tag2-Kras (G13D) in this assay kit is recognized by a Terbium-labeled anti-Tag2 antibody (HTRF donor). If Kras binds to a fluorescence- labeled GTP (HTRF acceptor), the donor and the acceptor will be brought in close proximity. Excitation of Terbium (340 nm) generates fluorescence resonance energy transfer (FRET) to the fluorescence- labeled GTP acceptor, which consequently fluoresces at 665 nm (figure below). Thus, GTP binding to Kras can be quantitively measured by calculation of the fluorescent ratio of 665 nm/620 nm. The inhibitor blocking the nucleotide exchange will reduce the HTRF signal.

Application

High throughput screening of compounds that inhibit Kras activation for drug discovery. Aurora Biolabs LLC, San Diego, CA 92121; www.aurorabiolabs.com; 1

Instrument Required

A HTRF® certified microplate reader capable of measuring Time Resolved Fluorescence Resonance Energy Transfer (TR-FRET) is required.

Kit Components

Materials Not Supplied

• Microplate reader, HTRF® certified microplate reader (such as Tecan M1000 or Tecan Spark, etc.)
• 0.5 M DTT
• Adjustable micro-pipettor
• Sterile Tips

Assay Protocol

1. Step 1. Prepare 1X assay buffer containing 1 mM DTT (1X DTT-containing assay buffer) For example, mix 996 µl distilled water with 1000 µl of 2X assay Buffer (Catalogue number: 5727- NK-B) and 4 µl of 0.5 M DTT. Make only enough 1X DTT-containing assay buffer as needed for the assay. Store the remaining 2X assay buffer at -20°C.
2. Step 2. Prepare the inhibitor compound solution
3. Step 3. Prepare Kras solution Thaw Kras (G13D) protein on ice. Upon first thaw, briefly spin tube to recover the full contents at the bottom of the tube. Make aliquots of the enzyme for single use. Store remaining undiluted enzyme at -80°C. Note: Kras protein is sensitive to freeze/thaw cycles. Limit number freeze-thaw cycles for best results. Do not re-use the diluted protein. Dilute the Kras protein to 800-fold (1 µL Kras G13D + 799 µL 1X assay buffer containing DTT). Add 8 µl of diluted protein solution to the positive control and inhibitor test wells. Add 8 µl of 1X assay buffer containing DTT) to the negative control wells.
4. Step 4. Add inhibitor Add 2 µl of diluted compound solution to each inhibitor test well. Add 2 µl of inhibitor solvent solution to each of negative and positive control well. Incubate at room temperature for 30 minutes (optional).
5. Step 5. Prepare dye solution Dilute Terbium-labeled anti-Tag2 antibody 1:200 and dilute fluorescence-labeled GTP 1:40 in 1X DTT-containing assay buffer. For example: 1 µl of Terbium-labeled anti-Tag2 antibody + 5 µl of fluorescence-labeled GTP + 194 µl of 1X DTT-containing assay buffer. Add 10 µl of this dye mixture to each well.
6. Step 6. Incubate the reaction at room temperature for 30 minutes.
7. Step 7. Measure fluorescent intensity HTRF compatible microplate reader is needed to measure fluorescent intensity of the samples. Fluorescent intensity should be measured twice:
8. Step 8. Excitation wavelength at 340 nm and emission at 620 nm.
9. Step 9. Excitation wavelength at 340 nm and emission at 665 nm. Negative Control Positive Control Inhibitor Test

Data Analysis

Calculate the HTRF signal (ratio of the fluorescent intensity at 665 mm/620 mm) of each well. Calculate percentage activity In the absence of the compound (positive control), the sample signal (P) is defined as 100% activity. In the absence of enzyme (negative control), the sample signal (N) is defined as 0% activity. The percent activity in the presence of each compound is calculated according to the following equation: % activity = (S-N)/(P-N) X100, where S= the sample signal in the presence of the compound.

Assay Validation